YETI Holdings
YETI
Halozyme Therapeutics
HALO
eBay
EBAY
4
Constellation Brands
STZ
5
Workday
WDAY
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 193.57%109.43M | -31.21%799.06M | -4.81%274.32M | 41.46%214.04M | -27.48%273.43M | -89.20%37.28M | -19.10%1.16B | -14.40%288.17M | -60.10%151.31M | 43.29%377.03M |
Net income from continuing operations | 1,109.99%30.23M | -46.14%116.09M | 728.83%69.13M | -49.82%30.06M | -68.38%19.89M | -102.89%-2.99M | -72.05%215.52M | -107.40%-10.99M | -69.25%59.9M | -71.33%62.9M |
Operating gains losses | -131.67%-15.66M | 65.70%-22.89M | 29.99%-12.62M | 122.39%2.62M | 58.59%-6.13M | 69.60%-6.76M | -64.33%-66.75M | 1.41%-18.02M | 24.51%-11.68M | -309.11%-14.81M |
Depreciation and amortization | -1.84%196.73M | 7.85%792.8M | 1.51%197.48M | 1.02%197.52M | 14.18%197.39M | 16.42%200.41M | 11.41%735.1M | 15.59%194.55M | 17.35%195.52M | 5.61%172.89M |
Deferred tax | -64.08%-22.43M | -306.44%-22.26M | -157.98%-694K | -46.55%9.4M | -158.70%-17.3M | -938.98%-13.67M | -65.05%10.78M | -95.97%1.2M | 393.38%17.59M | -0.01%-6.69M |
Other non cash items | -19.68%39.21M | -18.40%150.01M | -76.87%15.92M | -10.76%50.5M | 5.41%34.77M | 91.97%48.81M | 107.55%183.84M | 174.71%68.83M | 212.29%56.59M | 34.49%32.99M |
Change In working capital | 38.36%-118.66M | -388.70%-233.69M | -106.04%-3.04M | 53.75%-77.06M | -70.01%38.92M | -385.49%-192.5M | 208.35%80.95M | 400.85%50.37M | -1,537.97%-166.6M | 189.52%129.75M |
-Change in receivables | -270.51%-43.54M | -28.13%106.56M | -27.58%47.32M | 100.67%572K | -68.07%33.13M | -60.33%25.54M | 22,957.39%148.26M | 10.99%65.35M | -265.49%-85.19M | 225.90%103.73M |
-Change in payables and accrued expense | 78.29%-37.69M | -413.58%-206.75M | -129.09%-14.5M | 44.41%-19.67M | -96.58%1.07M | -961.68%-173.66M | 584.15%65.93M | 205.83%49.83M | -82.20%-35.38M | 153.57%31.33M |
-Change in other current liabilities | 34.67%-35.46M | -45.91%-175.9M | 44.81%-28.93M | -20.88%-55.55M | -217.64%-37.16M | -417.40%-54.27M | -181.05%-120.55M | -331.78%-52.41M | -318.40%-45.95M | -11.36%-11.7M |
-Change in other working capital | -119.88%-1.97M | 434.00%42.4M | 43.94%-6.95M | -2,713.95%-2.42M | 555.72%41.87M | 249.80%9.89M | 32.62%-12.7M | 24.44%-12.39M | 99.09%-86K | -0.88%6.39M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 193.57%109.43M | -31.21%799.06M | -4.81%274.32M | 41.46%214.04M | -27.48%273.43M | -89.20%37.28M | -19.10%1.16B | -14.40%288.17M | -60.10%151.31M | 43.29%377.03M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 61.20%-54.22M | 38.18%-759.12M | -0.08%-140.1M | 46.41%-360.18M | 45.54%-119.09M | 29.17%-139.75M | -90.04%-1.23B | 51.32%-140M | -335.48%-672.04M | -132.35%-218.69M |
Net PPE purchase and sale | 64.71%-49.86M | 27.44%-565.23M | -11.52%-156.74M | 31.68%-149.86M | 46.21%-117.33M | 29.70%-141.3M | -26.22%-778.98M | 46.04%-140.54M | -32.61%-219.34M | -151.16%-218.11M |
Net investment purchase and sale | --0 | -85.24%530K | --0 | --0 | --0 | -82.88%530K | 349.48%3.59M | --0 | --0 | 24.37%495K |
Net other investing changes | -525.81%-4.36M | 57.05%-194.43M | 6,928.87%16.32M | 53.53%-210M | -64.59%-1.77M | 72.22%1.02M | -1,539.79%-452.63M | 99.15%-239K | -4,001.52%-451.91M | 86.02%-1.07M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 61.20%-54.22M | 38.18%-759.12M | -0.08%-140.1M | 46.41%-360.18M | 45.54%-119.09M | 29.17%-139.75M | -90.04%-1.23B | 51.32%-140M | -335.48%-672.04M | -132.35%-218.69M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -243.35%-76.3M | -192.51%-139.4M | 37.30%-84.9M | 158.35%127.79M | -143.12%-160.07M | 83.49%-22.22M | 119.98%150.69M | -2,353.79%-135.4M | 125.18%49.47M | 262.02%371.22M |
Net issuance payments of debt | -130.86%-23.52M | -110.65%-27.88M | 19.63%-151.8M | 138.27%171.07M | -125.71%-123.37M | 175.50%76.22M | 174.40%261.78M | -1,547.13%-188.87M | 142.88%71.79M | 995.20%479.8M |
Net common stock issuance | 11.86%1.07M | 2.30%5.33M | 14.19%1.15M | 9.30%1.07M | 0.89%2.16M | -12.25%953K | 101.78%5.21M | -23.69%1.01M | -7.21%978K | 101.41%2.14M |
Cash dividends paid | -13.14%-29.31M | -14.27%-104.15M | -14.59%-25.9M | -14.61%-25.91M | -15.14%-26.43M | -12.73%-25.91M | -16.40%-91.15M | -17.14%-22.6M | -17.21%-22.61M | -17.22%-22.96M |
Net other financing activities | 66.61%-24.54M | 49.53%-12.69M | 22.10%91.64M | -2,547.70%-18.43M | 85.85%-12.42M | -525.52%-73.49M | 20.66%-25.15M | 12,672.19%75.06M | 93.55%-696K | -1,764.10%-87.76M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -243.35%-76.3M | -192.51%-139.4M | 37.30%-84.9M | 158.35%127.79M | -143.12%-160.07M | 83.49%-22.22M | 119.98%150.69M | -2,353.79%-135.4M | 125.18%49.47M | 262.02%371.22M |
Net cash flow | ||||||||||
Beginning cash position | -21.17%370.23M | 21.89%469.69M | -29.76%320.91M | -63.45%339.26M | -13.45%344.99M | 21.89%469.69M | 10.09%385.35M | 33.69%456.91M | 196.22%928.17M | 6.74%398.61M |
Current changes in cash | 83.08%-21.09M | -217.92%-99.46M | 285.93%49.32M | 96.11%-18.35M | -101.08%-5.73M | -1,040.17%-124.7M | 138.78%84.34M | -70.68%12.78M | -1,758.03%-471.26M | 981.03%529.56M |
End cash Position | 1.20%349.14M | -21.17%370.23M | -21.17%370.23M | -29.76%320.91M | -63.45%339.26M | -13.45%344.99M | 21.89%469.69M | 21.89%469.69M | 33.69%456.91M | 196.22%928.17M |
Free cash flow | 85.10%-23.04M | -122.30%-20.09M | -32.07%47.57M | 96.91%-5.69M | -22.46%92.67M | -282.30%-154.63M | -85.82%90.07M | 113.29%70.03M | -203.54%-184.29M | -9.85%119.51M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |